drugset / Trial / NCT00238784
SOLO-Symbicort® in the Treatment of Persistent Asthma in Adolescents & Adults
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to compare Symbicort Single Inhaler treatment with the Best Conventional Practice in patients with persistent asthma
Timeline
- Start
- 2004-05
- Primary completion
- 2005-10
- Completion
- 2005-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Budesonide | Small molecule | 160 ug | Inhaled |
| Subject | Formoterol | Other / unclassified | 4.5 ug | Inhaled |